期刊文献+

大肠表面型病变组织学和P53、c-Myc表达 被引量:1

The histology of colorectal superficial lesions and expressions of P53 and c-Myc
下载PDF
导出
摘要 目的研究人类大肠表面型病变的组织学特征及P53、c-Myc在大肠癌演变过程中的意义。方法采用免疫组化二步法,研究20例正常大肠黏膜、31例表面型病变、51例隆起型病变及31例大肠腺癌组织中P53、c-Myc的表达情况。结果大肠表面型病变的组织学均为腺瘤,且全部伴有不同程度的异型增生,与隆起型病变比较,两组中、重度异型增生的比例均有显著差异(P<0.05);大肠表面型病变的P53、c-Myc表达分别为3.2%及25.8%,其中P53表达与隆起型病变比较结果无差异(P>0.05),但c-Myc的表达两组有显著差异(P<0.05)。结论大肠表面型病变与大肠癌关系密切,P53、c-Myc在其向大肠癌演变过程中起重要作用。 Objective To study the histology characters of colorectal superficial lesions and the significance of P53 and c-Myc in colorectal cancer evolvement. Method Two-step immunohistochemistry was used to analyze the expression of P53 and c-Myc in 20 normal colorectal mucosa,31 superficial lesions,51 protruded lesions and 31 adenocarcinomas. Result All colorectal superficial lesions were adenomas with different grade dysplasia. Comparing with protruded lesions, the difference of moderate and severe dysplasia between the two kinds lesions had significant difference (P 〈 0.05). The expression rates of P53 and c-Myc in colorectal superficial lesions were 3.2% and 25.8% , respectively. Comparing with protruded lesions, no significant difference was observed in P53 expression(P 〉 0.05), but on the contrary to c-Myc(P 〈 0.05). Conclusion Colorectal superficial lesions are highly correlated with colorectal cancer, P53 and c-Myc play important roles in colorectal cancer evolvement.
出处 《胃肠病学和肝病学杂志》 CAS 2007年第5期455-458,共4页 Chinese Journal of Gastroenterology and Hepatology
基金 广东省医学科研基金项目(A2004747)
关键词 表面型病变 隆起型病变 P53 C-MYC 免疫组化 Superficial lesions Protruded lesions P53 c-Myc lmmunohistochemistry
  • 相关文献

参考文献15

  • 1回允中,主译.诊断外科病理学[M].第3版.北京:北京大学医学出版社,2002.1413-1468.
  • 2许敬尧,执笔.全国大肠癌病理研究统一规范[M].第2版.2002.
  • 3刘凛.卵巢肿瘤中p53、iNOS表达及二者相关性研究[J].中国医师进修杂志,2006,29(1):22-25. 被引量:3
  • 4Mosnier JF, Perret AG, Vindimian M, et al. An immunohistochemical study of the simultaneous expression of bcl-2 and P53 oncopreteins in epithelial tumors of the colon and rectum [ J ]. Arch Pathol Lab Med,1996,120(7) :654-659.
  • 5Rembacken B J, Fujii T,Cairns A,et al. Flat and depressed colonic neoplasms:a prospective study of 1000 colonoscopies in the U K [ J ]. Lancet,2000,355(9211 ) :1211-1214.
  • 6Sugihara K,Muto T. Flat adenoma: A new concept in the pathogenesis of colorectal carcinoma[ J ]. Coloproctotogy, 1995,17 : 114-118.
  • 7张晓慧,许岸高,钟旭辉,刘集鸿.大肠黏膜表面型病变的癌变率研究[J].中国内镜杂志,2005,11(7):711-713. 被引量:5
  • 8Brabletz T, Herrmann K, Jung A, et al. Expression of nuclear beta-catenin and c-Myc is correlated with tumor size but not with proliferative activity of colorectal adenomas [ J ]. Am J Pathol, 2000, 156 ( 3 ) : 865 -870.
  • 9孙燕翔,陈崇稼,周汉高,师英强,潘伯荣,冯蔚鹰.c-myc和p53在大肠腺瘤与大肠癌中的表达[J].华人消化杂志,1998,6(12):1054-1056. 被引量:5
  • 10Hermeking H, Eick D. Mediation of c-Myc-induced apoptosis by P53 [J]. Science, 1993,265(5181 ) :2091-2093.

二级参考文献33

共引文献34

同被引文献11

  • 1白玲,陈乃玲,张昶,陈昊,赵文海.结肠癌患者细胞凋亡与预后意义的初步研究[J].胃肠病学和肝病学杂志,2006,15(4):376-378. 被引量:5
  • 2来茂德.大肠癌.武忠弼,杨光华主编.中华外科病理学.上卷.北京:人民卫生出版社,2002.744—756.
  • 3Kroemer G, Martin SJ. Caspase-independent cell death[J]. Nat Med, 2005 ,11(7) :725-730.
  • 4濱野照明.アボト-シスを制御する细胞内分子とその機序[J].臨床免疫,2002,38(Suppl 20):126-132
  • 5Guicciardi MS, Bronk SF, Werneburg NW, et al. Bid is upstream of lysosome-mediated caspase 2 activation in tumor necrosis factorα-induced hepalocyte apopiosis[J]. Gastroenterology, 2005, 129 (1): 269-284.
  • 6Bennett MW, O' Connell J, Houston A, et al. Fas ligand upregulation is an early event in colonic carcinogenesis[ J ]. J Clin Pathol,2001 ,54 (8) :598-604.
  • 7Andreola G, Rivoltini L, Caslelli E, et al. Induction of lymphocyte apoptosis by tumor cell secretionof Fasl-bearing microvesicles[ J ]. J Exp Med,2002, 195(10):1303-1316.
  • 8Huber V ,Fais S,Iero M,et al. Human colorectal cancer cells induce T- cell death through release of proapoptotic microvesicles:role in immune escape [J], Gastroenterology ,2005,128 ( 7 ) : 1796-1804.
  • 9Mehlen P,Puisieux A. Metastasis: a question of life or death[J]. Nat Rev Cancer,2006,6 (6):449-458.
  • 10Martin SS. Ridgeway AG, Pinkas J,et al. A cytoskeleton-based functional genetic screen identifies Bcl-xL as an enhancer of mataslasis, but not primary tumor growth [J]. Oncogene, 2004. 23 (26): 4641-4645.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部